Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $759,598 - $911,922
-67,400 Reduced 61.11%
42,900 $512,000
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $245,560 - $303,800
28,000 Added 34.02%
110,300 $1.19 Million
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $46,032 - $54,480
4,800 Added 6.19%
82,300 $811,000
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $699,050 - $797,474
77,500 New
77,500 $773,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.